NEW YORK, NY / ACCESS Newswire / January 22, 2025 / If you suffered a loss on your Rentokil Initial plc (NYSE:RTO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/rentokil-initial-plc-lawsuit-submission-form?prid=124498&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or […]

NEW YORK, NY / ACCESS Newswire / January 22, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Polestar Automotive Holding UK PLC ("Polestar Automotive Holding UK PLC") (NASDAQ:PSNY) concerning possible violations of federal securities laws. On January 16, 2025, Polestar filed a report with the U.S. Securities and Exchange

NEW YORK, NY / ACCESS Newswire / January 22, 2025 / If you suffered a loss on your Micron Technology, Inc. (NASDAQ:MU) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/micron-technology-inc-lawsuit-submission-form?prid=124496&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

NEW YORK CITY, NY / ACCESS Newswire / January 22, 2025 / WHY: New York, N.Y., January 22, 2025. Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Nextracker Inc. (NASDAQ:NXT) between February 1, 2024 and August 1, 2024, both dates inclusive (the "Class Period"), of the important February

(NYSE:CCI), HOUSTON, Jan. 22, 2025 (GLOBE NEWSWIRE) — Crown Castle Inc. (NYSE: CCI) (“Crown Castle”) announced today certain year-end tax reporting information for its 2024 distributions. The following table summarizes, for income tax purposes, the nature of distributions paid to holders of Crown Castle Common Stock, par value $.01 per share (“Common Stock”), presented on

Akeso, Inc. (9926.HK) (“Akeso” or the “Company”) is excited to announce that the prestigious medical journal Nature Medicine published the results of the company's independently developed PD-1/CTLA-4 bispecific antibody cadonilimab in combination with oxaliplatin and capecitabine for the first-line treatment of unresectable locally advanced or metastatic gastric or gastroesophageal junction (G/GEJ) adenocarcinoma in a Phase

https://mma.prnewswire.com/media/2598307/32a64817_10ba_407b_947c_76bd790799f6_Logo.jpg Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of stock or sellers of puts of Capri Holdings Limited (NYSE:CPRI) between August 10, 2023 and October 24, 2024, both dates inclusive (the “Class Period”), of the importantFebruary 21, 2025 lead plaintiff deadline. So what: If you purchased Capri stock or sold

(NYSE:UIS), NEW YORK, Jan. 22, 2025 (GLOBE NEWSWIRE) — Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Unisys Corporation (NYSE: UIS) resulting from allegations that Unisys may have issued materially misleading business information to the investing public. So What: If you purchased

NEW YORK, NY / ACCESS Newswire / January 22, 2025 / Rosen Law Firm PA WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Shares ("ADS") of Rentokil Initial plc (NYSE:RTO) between December 1, 2023 and September 10, 2024, both dates inclusive (the "Class Period"), of the important January

(NYSE:IIPR), Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Jan. 22, 2025 (GLOBE NEWSWIRE) — The Portnoy Law Firm advises Innovative Industrial Properties, Inc. (“Innovative Industrial Properties” or the “Company”) (NYSE: IIPR) investors of a class action representing investors that bought securities between February 27,